AI Article Synopsis
- Mucormycosis, a serious fungal infection, is increasingly common among diabetics due to its association with COVID-19 and corticosteroid use.
- Early detection and treatment are crucial in reducing the severe impacts of this infection, often involving antifungals and surgical procedures.
- A case series highlights how prosthodontic rehabilitation helped nine patients recovering from this infection, focusing on restoring function and aesthetics after significant tissue loss.
Article Abstract
Mucormycosis, a rare fungal infection seen in diabetes, is now very frequent owing to the deadly triad of COVID-19 infection, diabetes, and rampant use of corticosteroids. Early diagnosis and treatment can reduce the mortality and morbidity of this lethal fungal infection. Treatment principles may include antifungal agents along with surgical debridement or resection. The surgically removed palate can have a devastating effect on the appearance and speech of the patient. Obturators allow patients to eat and drink without any suspicion of food entering the oroantral cavities/pharynx during mastication. This case series presented the prosthodontic rehabilitation of nine post-COVID rhinocerebral mucormycosis-infected patients with complete or partial defects.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041217 | PMC |
| http://dx.doi.org/10.4103/jfmpc.jfmpc_975_22 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!